EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease

Min Kyung Park iD, Yun Bin Lee, Se-Mi Jung, Yoo-Wook Kwon, Jung-Hwan Yoon

Stem Cells Translational Medicine · 16.10.2026 · 15 (11)

DOI: 10.1093/stcltm/szag089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 30.10.2026. Verfasst von Min Kyung Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seou…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Oxidative Stress, Fatty Liver, Human Embryonic Stem Cells. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yuhan Pharmaceuticals, Seoul National University Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common chronic liver disease with significant clinical burden. This study investigated the therapeutic potential of embryonic stem cell-derived mesenchymal stem cells (ESC-MSCs) in cellular and murine models of MASLD.

Methods

HepG2 cells were treated with palmitic acid (PA) and then co-cultured with ESC-MSCs. C57BL/6 mice were fed a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) or a standard diet for 24 weeks. Either ESC-MSCs or vehicles were administered via tail vein injection at week 20. Lipid accumulation was assessed using Oil red O staining. Mitochondrial status was assessed using MitoTracker Red fluorescence, mtDNA content, reactive oxygen species (ROS), and antioxidant parameters.

Results

ESC-MSC co-culture reduced PA-induced lipid accumulation, restored mitochondrial activity, decreased ROS, and increased superoxide dismutase (SOD) activity and glutathione redox balance. Expression of phosphorylated AMPK (p-AMPK), PGC1α, and PPARα was significantly upregulated. In CDAHFD-fed mice, ESC-MSC transplantation attenuated hepatic steatosis, restored mitochondrial DNA content, and reduced ROS accumulation with increased SOD activity and glutathione ratio. Hepatic expression of p-AMPK, PGC1α, and PPARα was also enhanced. These effects were abrogated by Compound C, an AMPK inhibitor. ESC-MSCs secreted hepatocyte growth factor (HGF), which activated AMPK, suggesting an HGF–AMPK axis may serve as a potential paracrine mechanism.

Conclusion

ESC-MSCs ameliorated hepatic steatosis in MASLD models by restoring mitochondrial activity and reducing oxidative stress, possibly involving HGF-associated AMPK pathway modulation. These findings support the potential of ESC-MSC therapy for MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsOxidative StressFatty LiverHuman Embryonic Stem CellsMitochondriaMesenchymal Stem Cell TransplantationHumansAnimalsMiceMice, Inbred C57BLReactive Oxygen SpeciesHep G2 CellsCoculture TechniquesMale

Stichwörter der Autor:innen

embryonic stem cellmesenchymal stem cell transplantationmetabolic dysfunction–associated steatotic liver diseasemitochondria

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.
  • Biomedical Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.

ORCID-Profile: Min Kyung Park

Förderung

  • Yuhan Pharmaceuticals
  • Seoul National University Hospital Research Fund

Zitieren

APA

Park, M. K., Lee, Y. B., Jung, S. M., Kwon, Y. W., & Yoon, J. H. (2026). Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease. Stem Cells Translational Medicine, 15(11). https://doi.org/10.1093/stcltm/szag089

Vancouver

Park MK, Lee YB, Jung SM, Kwon YW, Yoon JH. Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease. Stem Cells Translational Medicine. 2026;15(11). doi:10.1093/stcltm/szag089

BibTeX
@article{Park2026,
  author = {Park, Min Kyung and Lee, Yun Bin and Jung, Se-Mi and Kwon, Yoo-Wook and Yoon, Jung-Hwan},
  title = {Human embryonic stem cell–derived mesenchymal stem cells ameliorate mitochondrial oxidative dysfunction in metabolic dysfunction–associated steatotic liver disease},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  volume = {15},
  number = {11},
  doi = {10.1093/stcltm/szag089}
}
Kostenlos starten →